Nicardipine Hydrochloride

CAS 54527-84-3 14 current records 3 historicalSmall Molecule

Who holds supplier records for Nicardipine Hydrochloride? 14 organisations hold a current record for Nicardipine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 1 of them holds a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (6), China (3), Italy (2), France (1) and 1 other country (1); not recorded for 1.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Nicardipine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/nicardipine-hydrochloride

Reading the evidence

  • 14 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 8 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (14)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Nicardipine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India6China3Italy2France1United States1Country not recorded for 1
Need Nicardipine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (1)

Certificates of Suitability on the EDQM register for Nicardipine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
CEP 2024-005 - Rev 00
Nicardipine hydrochloride
Jun 2025—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (3)

Organisations whose Type II DMFs for Nicardipine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 3 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Nicardipine Hydrochloride is a calcium channel blocker used in the management of hypertension and angina. It works by relaxing blood vessels so blood can flow more easily.

Chemical identity

IUPAC name
5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydrochloride
Canonical SMILES
CC1=C(C(C(=C(N1)C)C(=O)OCCN(C)CC2=CC=CC=C2)C3=CC(=CC=C3)[N+](=O)[O-])C(=O)OC.Cl
InChIKey
AIKVCUNQWYTVTO-UHFFFAOYSA-N
Synonyms
Cardene API, barizin, cardene, cardepine, dacarel, lescodil, loxen, lecibra, lecibral, nerdipina, nicant, nicapress

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Dihydropyridine Calcium Channel Blocker
Mechanism of action
Calcium Channel Antagonists; Cytochrome P450 2C19 Inhibitors; Cytochrome P450 2C8 Inhibitors; Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A4 Inhibitors
Chemical structure
Dihydropyridines

Therapeutic areas

CardiovascularHypertensionAngina

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Nicardipine Hydrochloride?

14 organisations hold an active US FDA Type II Drug Master File or a CEP for Nicardipine Hydrochloride: LUSOCHIMICA SPA (Italy), MSN Laboratories Private Limited (India), CHEMWERTH INC (France), GLAND PHARMA LTD (India), HIKMA PHARMACEUTICALS, MAHI DRUGS PRIVATE LIMITED (India), MAITHRI DRUGS PRIVATE LTD (India) and METROCHEM API PRIVATE LTD (India), and 6 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Nicardipine Hydrochloride Drug Master Files are active?

LUSOCHIMICA SPA (DMF 21625, 9493), MSN Laboratories Private Limited (DMF 37582), CHEMWERTH INC (DMF 19552), GLAND PHARMA LTD (DMF 29198), HIKMA PHARMACEUTICALS (DMF 23280), MAHI DRUGS PRIVATE LIMITED (DMF 40013), MAITHRI DRUGS PRIVATE LTD (DMF 44251) and METROCHEM API PRIVATE LTD (DMF 40235) and 6 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Nicardipine Hydrochloride records mean?

3 organisations have only inactive Type II DMFs for Nicardipine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Nicardipine Hydrochloride have a European Certificate of Suitability?

Yes. 1 organisation holds a valid CEP for Nicardipine Hydrochloride on the EDQM register, including MSN LABORATORIES PRIVATE LIMITED Rudraram Village (IN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Nicardipine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Nicardipine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.